Human corneal equivalent as cell culture model for in vitro drug permeation studies

被引:126
作者
Reichl, S
Bednarz, J
Müller-Goymann, CC
机构
[1] Tech Univ Braunschweig, Inst Pharmazeut Technol, D-38106 Braunschweig, Germany
[2] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Augenheilkunde, Hamburg, Germany
关键词
D O I
10.1136/bjo.2003.028225
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aims: For the study of transcorneal in vitro permeation of ophthalmic drugs, excised animal cornea or corneal epithelial cell culture are frequently used as a replacement for the human cornea. The main purposes of this study were to reconstruct a complete human organotypic cornea equivalent, consisting of all three different cell types ( epithelial, stromal, and endothelial); to test the barrier function of this bioengineered human cornea using three different model drugs ( pilocarpine hydrochloride (PHCl), befunolol hydrochloride (BHCl), and hydrocortisone ( HC)); and to determine its usefulness as an in vitro model for prediction of ocular drug absorption into the human eye. Methods: A multilayer tissue construct was created step by step in Transwell cell culture insert using SV-40 immortalised human endothelial and epithelial cells and native stromal cells ( fibroblasts). Morphology was characterised by light microscopy using routine H&E staining. Scanning electron microscopy was used to evaluate ultrastructural features. Ocular permeation of drugs across the human cornea construct was tested using modified Franz cells and compared with data obtained from excised porcine cornea and previously described porcine cornea constructs. Results and conclusion: The cornea construct exhibited typical corneal structures such as a monolayer of hexagonally shaped endothelial cells and a multilayered epithelium consisting of seven to nine cell layers with flat superficial cells. The formation of microplicae and microvilli was also confirmed. The human cornea construct showed similar permeation behaviour for all substances compared with excised porcine cornea. However, permeability ( permeation coefficients K-p) of the human cornea equivalent ( PHCl 13.4 . 10(-6) (SD 3.01 . 10(-6)); BHCl 9.88 . 10(-6) (SD 1.79 . 10(-6)); HC 5.41 . 10(-6) (SD 0.40 . 10(-6)) cm/s) was about 1.6 - 1.8 fold higher than excised porcine cornea. Compared with data from the porcine cornea construct the cultivated human equivalent showed a decreased permeability. The reconstructed human cornea could be appropriate to predict drug absorption into the human eye.
引用
收藏
页码:560 / 565
页数:6
相关论文
共 39 条
  • [11] FUJITA T, 1986, ZELLEN GEWEBE REM AT
  • [12] Can we produce a human corneal equivalent by tissue engineering?
    Germain, L
    Carrier, P
    Auger, FA
    Salesse, C
    Guérin, SL
    [J]. PROGRESS IN RETINAL AND EYE RESEARCH, 2000, 19 (05) : 497 - 527
  • [13] Goskonda Venkat R., 1999, Pharmacy and Pharmacology Communications, V5, P111
  • [14] Permeability of chemical delivery systems across rabbit corneal (SIRC) cell line and isolated corneas: A comparative study
    Goskonda, VR
    Hill, RA
    Khan, MA
    Reddy, IK
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2000, 5 (03) : 409 - 416
  • [15] Permeability characteristics of novel mydriatic agents using an in vitro cell culture model that utilizes sirc rabbit corneal cells
    Goskonda, VR
    Khan, MA
    Hutak, CM
    Reddy, IK
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (02) : 180 - 184
  • [16] Functional human corneal equivalents constructed from cell lines
    Griffith, M
    Osborne, R
    Munger, R
    Xiong, XJ
    Doillon, CJ
    Laycock, NLC
    Hakim, M
    Song, Y
    Watsky, MA
    [J]. SCIENCE, 1999, 286 (5447) : 2169 - 2172
  • [17] KAHN CR, 1993, INVEST OPHTH VIS SCI, V34, P3429
  • [18] Beta adrenergic antagonist permeation across cultured rabbit corneal epithelial cells grown on permeable supports
    Kawazu, K
    Shiono, H
    Tanioka, H
    Ota, A
    Ikuse, T
    Takashina, H
    Kawashima, Y
    [J]. CURRENT EYE RESEARCH, 1998, 17 (02) : 125 - 131
  • [19] Kawazu K, 1999, INVEST OPHTH VIS SCI, V40, P1738
  • [20] Lee V H, 1986, J Ocul Pharmacol, V2, P67, DOI 10.1089/jop.1986.2.67